S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
EV Battery Maker Freyr Set For Major Global Expansion
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
MarketBeat: Week in Review 9/26 – 9/30
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse back in January – reveals his strategy: (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
OTCMKTS:CSLLY

CSL - CSLLY Stock Forecast, Price & News

$91.25
-1.34 (-1.45%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$91.25
$92.75
50-Day Range
$90.51
$104.62
52-Week Range
$85.07
$117.24
Volume
149,145 shs
Average Volume
59,759 shs
Market Capitalization
$88.00 billion
P/E Ratio
N/A
Dividend Yield
1.17%
Price Target
N/A

CSL MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.31mentions of CSL in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.80%
From $2.74 to $3.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

CSLLY stock logo

About CSL (OTCMKTS:CSLLY) Stock

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSLLY Stock News Headlines

CSL Limited (OTCMKTS:CSLLY) Short Interest Update
When might the CSL share price top $300 again?
CSL (OTCMKTS:CSLLY) Upgraded to "Buy" by Jefferies Financial Group
Carlisle (CSL) Stock Moves -1.65%: What You Should Know
4 Reasons Why You Should Invest in Carlisle (CSL) Stock Now
CSL FY net profit dips to $A3.2bln
CSL full-year net profit dips
See More Headlines
Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSLLY Company Calendar

Today
10/01/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CSLLY
Employees
30,000
Year Founded
1904

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.56 billion
Cash Flow
$2.99 per share
Book Value
$15.13 per share

Miscellaneous

Free Float
N/A
Market Cap
$88.00 billion
Optionable
Not Optionable
Beta
0.68

Key Executives

  • Mr. Paul R. Perreault B.A. (Age 65)
    MD, CEO & Exec. Director
    Comp: $4.87M
  • Ms. Joy Carolyn Linton B.Com. (Age 57)
    BComm, GAICD, Grad Dip AFI, Chief Financial Officer
    Comp: $2.15M
  • Dr. Paul F. McKenzie Ph.D. (Age 56)
    Chief Operating Officer
    Comp: $2.32M
  • Mr. Mark Dehring
    Head of Investor Relations
  • Mr. Gregory Boss B.S. (Age 61)
    BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel
  • Christina Hickie
    Sr. Mang. of Communications
  • Ms. Elizabeth Walker B.A. (Age 52)
    M.S., Exec. VP & Chief HR Officer
  • Dr. Karen Etchberger (Age 64)
    Exec. VP of Quality & Bus. Services
  • Dr. Wilfried Freudenberg
    Department Head of Albumin & Immunoglobulins Production
  • Ms. Jemimah Brennan
    Head of Communications - Asia Pacific













CSLLY Stock - Frequently Asked Questions

Should I buy or sell CSL stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CSLLY shares.
View CSLLY analyst ratings
or view top-rated stocks.

How have CSLLY shares performed in 2022?

CSL's stock was trading at $105.80 at the beginning of the year. Since then, CSLLY stock has decreased by 13.8% and is now trading at $91.2450.
View the best growth stocks for 2022 here
.

Are investors shorting CSL?

CSL saw a increase in short interest in September. As of September 15th, there was short interest totaling 8,000 shares, an increase of 81.8% from the August 31st total of 4,400 shares. Based on an average daily trading volume, of 71,700 shares, the days-to-cover ratio is currently 0.1 days.
View CSL's Short Interest
.

Is CSL a good dividend stock?

CSL (OTCMKTS:CSLLY) pays an annual dividend of $1.08 per share and currently has a dividend yield of 1.17%.
Read our dividend analysis for CSLLY.

What is CSL's stock symbol?

CSL trades on the OTCMKTS under the ticker symbol "CSLLY."

How do I buy shares of CSL?

Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CSL's stock price today?

One share of CSLLY stock can currently be purchased for approximately $91.25.

How much money does CSL make?

CSL (OTCMKTS:CSLLY) has a market capitalization of $88.00 billion and generates $10.56 billion in revenue each year.

How many employees does CSL have?

The company employs 30,000 workers across the globe.

How can I contact CSL?

CSL's mailing address is 45 Poplar Road, Parkville C3, 3052. The official website for the company is www.csl.com.au. The company can be reached via phone at (139) 389-1911, via email at bernard.ronchi@csl.com, or via fax at 61-3-9389-1434.

This page (OTCMKTS:CSLLY) was last updated on 10/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.